Vestcor Inc’s SpringWorks Therapeutics SWTX Stock Holding History

Vestcor Inc’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-250,000	Closed	-$11.7M	–	1261
2025 Q2	$11.7M	Buy	250,000 +190,000	+317%	+$8.45M	0.36%	66
2025 Q1	$2.65M	Buy	+60,000	New	+$2.76M	0.09%	245

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Vestcor Inc's SWTX Position: Q3 2025 in Review

Vestcor Inc sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 250,000 shares — an estimated $11.7M sold.

Vestcor Inc first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $11.7M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Vestcor Inc reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Vestcor Inc sold 250,000 SpringWorks Therapeutics shares in Q3 2025, an estimated $11.7M.
Vestcor Inc first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Vestcor Inc's SpringWorks Therapeutics position peaked at $11.7M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Vestcor Inc's 13F filing for Q3 2025, filed 13 Nov 2025.